BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, June 8, 2026
Home
»
Newsletters
» BioWorld
BioWorld
Oct. 5, 2009
View Archived Issues
AIDSVax Results Likely Not Enough to Rescue VaxGen
Read More
Orexigen's New Empatic Data: Nice Obesity-Partner Package
Read More
Money Raised By Biotech in 2009: Jan 1 – Oct 1, 2009
Read More
Week in Review
Read More
Word on the Street
Read More
Public Financing Of Biotechnology: September 2009
Read More
BioTech Money Raised By Month in 2009: January – September
Read More
Other Financings Of Public Biotechnology Companies: September 2009
Read More
Venture Capital And Other Investments In Private Biotechnology Companies: September 2009
Read More
Milestone Payments From Corporate Partners: September 2009
Read More
Stock Indexes
Read More
Stock Gainers and Losers For The Week
Read More
BioWorld Stock Report For Public Biotechnology Companies
Read More
Recent Data May Resurrect Both AIDSVax and HIV Field
News that an HIV vaccine actually worked could resurrect AIDSVax, a product most folks left for dead in 2003, while breathing new life into the HIV vaccine field.
Read More
Money Raised Year to Date
Read More
